Rhinitis | Ear, Nose & Throat Journal Skip to content Skip to navigation


Impaired mucociliary clearance in allergic rhinitis patients is related to a predisposition to rhinosinusitis

April 1, 2009  |  Ioannis Vlastos, MD, Ioannis Athanasopoulos, MD, PhD, Nicholas S. Mastronikolis, MD, PhD, Theodora Panogeorgou, MD, Vassilios Margaritis, MD, Stefanos Naxakis, MD, PhD, and Panos D. Goumas, MD


Although mucociliary clearance has been shown to be impaired in patients with allergic rhinitis and chronic rhinosinusitis, its exact role in relation to a predisposition to rhinosinusitis is unknown. To investigate this possible association, we conducted a prospective study of...

Long-term immunotherapy for perennial allergic rhinitis: Relationship of specific IgG levels to skin-prick test results and clinical symptoms and signs

December 1, 2008  |  Rauf Tahamiler, MD, Salih Canakcioglu, MD, Suleyman Yilmaz, MD, and Huseyin Isildak, MD


We studied 63 adults with perennial allergic rhinitis and positive skin-prick tests for Dermatophagoides pteronyssinus (Dp) and Dermatophagoides farinae (Df) who had not previously received any type of immunotherapy or pharmacotherapy for their condition. We...

Prevalence of autoimmune thyroid disease in chronic rhinitis

September 1, 2008  |  William R. Reisacher, MD, FACS, FAAOA


A retrospective, controlled study was undertaken to determine the prevalence of autoimmune thyroid disease in 111 adult patients with allergic (77) and nonallergic (34) rhinitis seen in a private ENT/allergy practice in the lower Hudson Valley, New York. The control group...

Onset of action of ciclesonide once daily in the treatment of seasonal allergic rhinitis

June 1, 2008  |  Piyush Patel, MD, Deepen Patel, MD, Sudeesha Kunjibettu, PhD, Nancy Hall, MS, and Mark A. Wingertzahn, PhD


Ciclesonide is an intranasal corticosteroid approved for the treatment of allergic rhinitis. We conducted a randomized, double-blind, parallel-group, placebo-controlled study to evaluate the time to onset of action of ciclesonide 200 μg once daily in 502 adults with seasonal...

Nodular fasciitis of the nasal cavity: A case report

December 1, 2007  |  David Mullin, MD, Fred W. Lindsay, DO, and Michael A. Keefe, MD


Nodular fasciitis is an uncommon tumor-like fibroblastic proliferation of the head and neck that is difficult to differentiate from its more malignant counterparts. Despite modern advances, making this distinction is challenging because the clinical presentation is nonspecific...

The effect of nasal steroid administration on intraocular pressure

July 1, 2007  |  Christos Spiliotopoulos, MD; Nicholas S. Mastronikolis, MD, PhD; Ioannis K. Petropoulos, MD; Ephigenia K. Mela, MD, PhD; Panos D. Goumas, MD, PhD; Sotirios P. Gartaganis, MD, PhD
The effect of systemic steroid administration on intraocular pressure (IOP) is well established. However, less...

Cell-mediated immunity in nasopharyngeal carcinoma and allergic rhinitis: A controlled study

May 1, 2007  |  Hsien Teik Wong, MS; Tengku A. Shahrizal, MS; Narayanan Prepageran, FRCS; Wye Keat Lim, FRCS; Rajagopalan Raman, MS

Nasal septal perforation secondary to rhinitis medicamentosa

June 1, 2006  |  Harold F. Keyserling, MD; John D. Grimme, MD; Daniel L.A. Camacho, MD; Mauricio Castillo, MD
Nasal septal perforation is a rarely reported complication of rhinitis medicamentosa. We describe such a...

Comparison of intranasal hypertonic Dead Sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis

July 1, 2005  |  Scott Cordray, DO, FAOCO; Jim B. Harjo, DO; Linda Miner, PhD
Intranasal corticosteroids are well known to be efficacious in the treatment of allergic rhinitis. Nasal...

Pediatric allergic rhinitis: Factors affecting treatment choice

March 1, 2005  |  Erwin W. Gelfand, MD
Allergic rhinitis is the most prevalent chronic allergic disease in children. Although it is not life-...

Charcot-Leyden crystals: Pathology and diagnostic utility

July 1, 2004  |  Liron Pantanowitz, MD; Karoly Balogh, MD


Subscribe to Rhinitis